Ancora Advisors LLC Acquires 157,130 Shares of ZimVie Inc. $ZIMV

Key Points

• Ancora Advisors LLC significantly increased its stake in ZimVie Inc. by 140.1%, owning 269,290 shares worth approximately $2.9 million.
• Other institutional investors like J. Goldman & Co LP and Gamco Investors INC. also increased their holdings, contributing to 95.63% institutional ownership of ZimVie.
• ZimVie recently reported earnings of $0.26 EPS, surpassing analyst expectations, and has received mixed ratings from analysts with a consensus rating of "Hold" and an average target price of $17.75.

Ancora Advisors LLC raised its holdings in ZimVie Inc. (NASDAQ:ZIMV - Free Report) by 140.1% in the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 269,290 shares of the company's stock after acquiring an additional 157,130 shares during the quarter. Ancora Advisors LLC owned approximately 0.97% of ZimVie worth $2,908,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. AlphaQuest LLC increased its position in ZimVie by 2,695.9% in the 1st quarter. AlphaQuest LLC now owns 8,947 shares of the company's stock valued at $97,000 after acquiring an additional 8,627 shares during the period. Quantbot Technologies LP bought a new stake in shares of ZimVie in the 1st quarter valued at $98,000. Hsbc Holdings PLC bought a new stake in shares of ZimVie in the 1st quarter valued at $144,000. Wealth Enhancement Advisory Services LLC boosted its stake in shares of ZimVie by 5.8% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 15,127 shares of the company's stock valued at $211,000 after purchasing an additional 836 shares during the last quarter. Finally, State of Wyoming boosted its stake in shares of ZimVie by 132.2% in the 1st quarter. State of Wyoming now owns 16,318 shares of the company's stock valued at $176,000 after purchasing an additional 9,291 shares during the last quarter. 95.63% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on ZIMV shares. Wall Street Zen lowered shares of ZimVie from a "strong-buy" rating to a "buy" rating in a research note on Friday, July 18th. B. Riley lowered shares of ZimVie from a "buy" rating to a "neutral" rating and set a $19.00 price objective on the stock. in a research note on Thursday, July 31st. Barclays raised shares of ZimVie from an "underweight" rating to an "equal weight" rating and upped their price objective for the company from $9.00 to $19.00 in a research note on Tuesday, July 22nd. Finally, UBS Group reduced their price objective on shares of ZimVie from $16.00 to $10.00 and set a "neutral" rating on the stock in a research note on Thursday, May 15th. Four equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $17.75.

ZimVie Stock Up 0.1%

NASDAQ ZIMV traded up $0.02 on Tuesday, hitting $18.91. 37,336 shares of the company were exchanged, compared to its average volume of 326,929. The company has a market cap of $533.31 million, a PE ratio of -27.01 and a beta of 2.20. ZimVie Inc. has a 12 month low of $8.15 and a 12 month high of $19.01. The stock has a fifty day moving average of $16.19 and a 200-day moving average of $12.17. The company has a current ratio of 2.37, a quick ratio of 1.60 and a debt-to-equity ratio of 0.56.

ZimVie (NASDAQ:ZIMV - Get Free Report) last released its quarterly earnings data on Wednesday, July 30th. The company reported $0.26 earnings per share for the quarter, beating analysts' consensus estimates of $0.21 by $0.05. ZimVie had a negative net margin of 4.39% and a positive return on equity of 6.37%. The firm had revenue of $116.66 million for the quarter, compared to analyst estimates of $112.60 million. As a group, analysts forecast that ZimVie Inc. will post 0.6 earnings per share for the current year.

About ZimVie

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.